Bertino; Joseph R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bertino; Joseph R..The latest application filed is for "targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase antibodies by in vivo cleavable linking moieties".

Company Profile

3.16.22

Bertino; Joseph R. - Branford CT
Bertino; Joseph R. - Brantford CT
Bertino; Joseph R. - New Brunswick NJ
Bertino; Joseph R. - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Anti-matriptase Antibodies By In Vivo Cleavable Linking Moieties App 20210299270 - Lin; Siang-Yo ; et al.	2021-09-30
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Matriptase Antibodies App 20210177985 - Lin; Siang-Yo ; et al.	2021-06-17
Use Of Multi-frequency Impedance Cytometry In Conjunction With Machine Learning For Classification Of Biological Particles App 20200333235 - Javanmard; Mehdi ; et al.	2020-10-22
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Matriptase Antibodies App 20190358340 - Lin; Siang-Yo ; et al.	2019-11-28
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies Grant 10,376,597 - Lin , et al. A	2019-08-13
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Anti-matriptase Antibodies By In Vivo Cleavable Linking Moietie App 20190151464 - Lin; Siang-Yo ; et al.	2019-05-23
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Matriptase Antibodies App 20180177889 - Lin; Siang-Yo ; et al.	2018-06-28
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies Grant 9,849,192 - Lin , et al. December 26, 2	2017-12-26
Targeting matriptase expressing tumor cells with chemotherapeutic agents conjugated to matriptase antibodies Grant 9,682,094 - Lin , et al. June 20, 2	2017-06-20
Specific delivery of toxins conjugated with antibodies to activate matripase Grant 9,549,993 - Lin , et al. January 24, 2	2017-01-24
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Matriptase Antibodies App 20160263244 - Lin; Siang-Yo ; et al.	2016-09-15
E2F as a target of hormone refractory prostate cancer Grant 9,314,497 - Bertino , et al. April 19, 2	2016-04-19
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Matriptase Antibodies App 20160015728 - Lin; Siang-Yo ; et al.	2016-01-21
Specific Delivery of Toxins Conjugated with Antiobodies to Activate Matripase App 20150250895 - Lin; Siang-Yo ; et al.	2015-09-10
E2f As A Target Of Hormone Refractory Prostate Cancer App 20150202248 - Bertino; Joseph R. ; et al.	2015-07-23
E2F as a target of hormone refractory prostate cancer Grant 8,822,421 - Bertino , et al. September 2, 2	2014-09-02
Targeting Tumor Cells With Chemotherapeutic Agents Conjugated To Matriptase Antibodies App 20120294800 - Lin; Siang-Yo ; et al.	2012-11-22
E2f As A Target Of Hormone Refractory Prostate Cancer App 20120093919 - Bertino; Joseph R. ; et al.	2012-04-19
Use Of Stem Cells For Wound Healing App 20110020291 - Banerjee; Debrabrata ; et al.	2011-01-27
Modulation Of Drug Sensitivity App 20100151004 - Banerjee; Debabrata ; et al.	2010-06-17
Antitumoral Treatments App 20090227490 - Bertino; Joseph R. ; et al.	2009-09-10
Antitumoral treatments Grant 7,576,188 - Bertino , et al. August 18, 2	2009-08-18
In-vivo energy depleting strategies for killing drug-resistant cancer cells Grant 7,514,413 - Martin , et al. April 7, 2	2009-04-07
Aplidine for multiple myeloma treatment Grant 7,381,703 - Bertino , et al. June 3, 2	2008-06-03
Treatment of cancer by reduction of intracellular energy and pyrimidines Grant 7,381,713 - Martin , et al. June 3, 2	2008-06-03
Aplidine for multiple myeloma treatment App 20070149445 - Bertino; Joseph R. ; et al.	2007-06-28
Aplidine for multiple myeloma treatment App 20060172926 - Bertino; Joseph R. ; et al.	2006-08-03
Synthesis of epothilones, intermediates thereto and analogues thereof Grant 6,965,034 - Danishefsky , et al. November 15, 2	2005-11-15
In-vivo energy depleting strategies for killing drug-resistant cancer cells App 20050159387 - Martin, Daniel S. ; et al.	2005-07-21
Double mutants of dihydrofolate reductase and methods of using same Grant 6,887,467 - Bertino , et al. May 3, 2	2005-05-03
Synthesis of epothilones, intermediates thereto and analogues thereof App 20030208080 - Danishefsky, Samuel J. ; et al.	2003-11-06
Double mutants of dihydrofolate reductase and methods of using same Grant 6,642,043 - Bertino , et al. November 4, 2	2003-11-04
Synthesis of epothilones, intermediates thereto and analogues thereof Grant 6,603,023 - Danishefsky , et al. August 5, 2	2003-08-05
Treatment of cancer by reduction of intracellular energy and pyrimidines App 20030139331 - Martin, Daniel S. ; et al.	2003-07-24
Synthesis of epothilones, intermediates thereto and analogues thereof App 20030105330 - Danishefsky, Samuel J. ; et al.	2003-06-05
Synthesis of epothilones, intermediates thereto and analogues thereof App 20030069277 - Danishefsky, Samuel J. ; et al.	2003-04-10
Synthesis of epothilones, intermediates thereto and analogues thereof Grant 6,204,388 - Danishefsky , et al. March 20, 2	2001-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.